Rutgers Cancer Institute of New Jersey University — New Brunswick, New Jersey

Rutgers Cancer Institute of New Jersey University is a clinical research site located in New Brunswick, New Jersey, United States 08901.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

Rutgers Cancer Institute of New Jersey University has participated in 1 clinical trials.

Therapeutic areas: Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier.

Sponsors: Celgene.

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Rutgers Cancer Institute of New Jersey University?

Rutgers Cancer Institute of New Jersey University has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Rutgers Cancer Institute of New Jersey University conducted?

Rutgers Cancer Institute of New Jersey University has 1 clinical trials on record. Their work covers Multiple Myeloma, Lymphoma, Large B-Cell, Diffuse, Pleiotropic Pathway Modifier.

Is Rutgers Cancer Institute of New Jersey University accredited by Crixeo Health?

Rutgers Cancer Institute of New Jersey University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Rutgers Cancer Institute of New Jersey University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.